Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 284

1.

Calming versus sedative effects of intramuscular olanzapine in agitated patients.

Battaglia J, Lindborg SR, Alaka K, Meehan K, Wright P.

Am J Emerg Med. 2003 May;21(3):192-8.

PMID:
12811711
[PubMed - indexed for MEDLINE]
2.

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.

Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, Koch M, Rizk R, Walker D, Tran P, Breier A.

J Clin Psychopharmacol. 2001 Aug;21(4):389-97.

PMID:
11476123
[PubMed - indexed for MEDLINE]
3.

Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM Jr, Feldman PD, Mintzer JE, Beckett LM, Breier A.

Neuropsychopharmacology. 2002 Apr;26(4):494-504.

PMID:
11927174
[PubMed - indexed for MEDLINE]
Free Article
4.

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.

Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P.

Arch Gen Psychiatry. 2002 May;59(5):441-8.

PMID:
11982448
[PubMed - indexed for MEDLINE]
5.

A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.

Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, Breier A.

Clin Ther. 2003 May;25(5):1420-8.

PMID:
12867218
[PubMed - indexed for MEDLINE]
6.

Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.

Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, Saunders JC, Krueger J, Bradley P, San L, Bernardo M, Reinstein M, Breier A.

Am J Psychiatry. 2001 Jul;158(7):1149-51.

PMID:
11431240
[PubMed - indexed for MEDLINE]
7.

Pharmacological management of acute agitation.

Battaglia J.

Drugs. 2005;65(9):1207-22. Review.

PMID:
15916448
[PubMed - indexed for MEDLINE]
8.

Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.

Lindborg SR, Beasley CM, Alaka K, Taylor CC.

Psychiatry Res. 2003 Jul 15;119(1-2):113-23.

PMID:
12860365
[PubMed - indexed for MEDLINE]
9.

Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.

Currier GW, Simpson GM.

J Clin Psychiatry. 2001 Mar;62(3):153-7.

PMID:
11305699
[PubMed - indexed for MEDLINE]
10.

Intramuscular aripiprazole in the control of agitation.

Currier GW, Citrome LL, Zimbroff DL, Oren D, Manos G, McQuade R, Pikalov AA 3rd, Crandall DT.

J Psychiatr Pract. 2007 May;13(3):159-69.

PMID:
17522559
[PubMed - indexed for MEDLINE]
11.

Continuum of care: stabilizing the acutely agitated patient.

Bellnier TJ.

Am J Health Syst Pharm. 2002 Sep 1;59(17 Suppl 5):S12-8. Review.

PMID:
12227082
[PubMed - indexed for MEDLINE]
12.

The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.

Jones B, Taylor CC, Meehan K.

J Clin Psychiatry. 2001;62 Suppl 2:22-4.

PMID:
11232747
[PubMed - indexed for MEDLINE]
13.
14.

An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.

Carlson CD, Cavazzoni PA, Berg PH, Wei H, Beasley CM, Kane JM.

J Clin Psychiatry. 2003 Aug;64(8):898-906.

PMID:
12927004
[PubMed - indexed for MEDLINE]
15.

Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study.

Freeman DJ, DiPaula BA, Love RC.

Pharmacotherapy. 2009 Aug;29(8):930-6. doi: 10.1592/phco.29.8.930.

PMID:
19637946
[PubMed - indexed for MEDLINE]
16.

Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.

Castle DJ, Udristoiu T, Kim CY, Sarosi A, Pidrman V, Omar AN, Rosales JI, Melamed Y, Isik T, Karagianis J, Treuer T.

World J Biol Psychiatry. 2009;10(1):43-53. doi: 10.1080/15622970802688051.

PMID:
19137460
[PubMed - indexed for MEDLINE]
17.

Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia.

Kinon BJ, Ahl J, Rotelli MD, McMullen E.

Am J Emerg Med. 2004 May;22(3):181-6.

PMID:
15138953
[PubMed - indexed for MEDLINE]
18.

Evaluating the usage of droperidol in acutely agitated persons with brain injury.

Stanislav SW, Childs A.

Brain Inj. 2000 Mar;14(3):261-5.

PMID:
10759043
[PubMed - indexed for MEDLINE]
19.

Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation.

Baker RW, Kinon BJ, Maguire GA, Liu H, Hill AL.

J Clin Psychopharmacol. 2003 Aug;23(4):342-8.

PMID:
12920409
[PubMed - indexed for MEDLINE]
20.

An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder.

Centorrino F, Meyers AL, Ahl J, Cincotta SL, Zun L, Gulliver AH, Kinon BJ, Houston JP.

Hum Psychopharmacol. 2007 Oct;22(7):455-62.

PMID:
17708578
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk